Home
>
National Drug Code (NDC)
>
Pomalyst
Pomalyst - 59572-504-21 - (Pomalidomide)
Drug Information of Pomalyst
| Product NDC: | 59572-504 |
| Proprietary Name: | Pomalyst |
| Non Proprietary Name: | Pomalidomide |
| Active Ingredient(s): | 4 mg/1 & nbsp; Pomalidomide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Pomalyst
| Product NDC: | 59572-504 |
| Labeler Name: | Celgene Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA204026 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130218 |
Package Information of Pomalyst
| Package NDC: | 59572-504-21 |
| Package Description: | 21 CAPSULE in 1 BOTTLE (59572-504-21) |
NDC Information of Pomalyst
| NDC Code | 59572-504-21 |
| Proprietary Name | Pomalyst |
| Package Description | 21 CAPSULE in 1 BOTTLE (59572-504-21) |
| Product NDC | 59572-504 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Pomalidomide |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20130218 |
| Marketing Category Name | NDA |
| Labeler Name | Celgene Corporation |
| Substance Name | POMALIDOMIDE |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
